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Purpose: To investigate the methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C genotypes and plasma
concentrations of total homocysteine (tHcy) in Pakistani patients with primary open angle glaucoma (POAG) and primary
closed angle glaucoma (PCAG).
Methods: This was a prospective case-control study. A total of 295 patients (173 POAG, 122 PCAG) and 143 age- and
sex-matched controls were subdivided into two ethnic groups, Punjabis (Punjab province, central Pakistan) and Pathans
(North-West Frontier Province, northern Pakistan). Genotypes of the MTHFR C677T and A1298C polymorphisms were
detected by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP). An enzyme-linked
immunosorbent assay was used to determine the total serum homocysteine (tHcy) levels. Associations were determined
by logistic regression analysis.
Results: Frequency distributions of genotypes and combined genotypes as well as homocysteine levels were obtained.
The overall distribution of the C677T genotype was found to be significantly associated with PCAG (CC 69%, CT 21%,
TT 10%; p=0.001, χ2=12.6), but not with POAG (CC 71%, CT 28%, TT 1%; p=0.98, χ2=0.02) as compared to the controls
(CC 71%, CT 29%, TT 1%). The Pathan cohorts revealed no association with the disease; however, the Punjabis
demonstrated a significant association with PCAG (CC 75%, CT 11%, TT 13%; p<0.001, χ2=17.2). PCAG in the Punjabi
subjects was also significantly associated with the A1298C polymorphism (AA 43%, AC 54%, CC 3%; p<0.001, χ2=33.9)
as compared to the controls. Combined genotype data showed no association with POAG; however, a significant
association with all combined genotypes was observed in the overall PCAG subjects (p<0.05, χ2=20.1). This difference
was particularly apparent in the TTAA and TTAC combinations that were completely absent in the control groups (p<0.05.
χ2=49.6). Mean serum tHcy levels were found to be significantly increased in the POAG (15.2±1.28 µmol/l, p<0.001) and
PCAG (20.8±4.8 µmol/l) groups as compared to the controls (10.0±0.97 µmol/l). The tHcy levels in the TT and AC
genotype were significantly elevated in the PCAG group (67±12.39 µmol/l, p<0.001; 23±5.94 µmol/l, p=0.027) as
compared to the controls.
Conclusion: The TT and AC genotypes of MTHFR C677T and A1298C polymorphisms and the combined genotype
TTAC were associated with PCAG in Punjabi subjects of Pakistani origin and correlated with the high serum tHcy levels
seen in these patients.
The  methylenetetrahydrofolate  reductase  (MTHFR)
enzyme  catalyzes  the  reduction  of  5,10-
methylenetetrahydrofolate  to  5-methyltetrahydrofolate,  the
methyl  donor  for  the  conversion  of  homocysteine  to
methionine [1]. Genetic polymorphisms in the MTHFR gene
are well established, the most extensively studied of which are
C677T  and  A1298C  single-nucleotide  polymorphisms
(SNPs).  The  C677T  SNP  results  in  a  missense  mutation
leading to the substitution of valine for alanine at position 222
of  the  MTHFR  enzyme,  causing  the  synthesis  of  a
thermolabile enzyme with a 50% reduction in activity [2-4].
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The other SNP, A1298C, which is located within the COOH-
terminal regulatory domain of the MTHFR, results in the
substitution of glutamate for an alanine residue [5,6] and has
also  been  associated  with  a  mild  reduction  in  enzymatic
activity  [7].  Reduced  MTHFR  enzyme  activity  is
subsequently  followed  by  increases  in  circulating
homocysteine levels (hyperhomocysteinemia) [8].
Glaucoma  is  an  optic  neuropathy  that  results  in
progressive damage to the visual field. It is one of the leading
causes of irreversible blindness in the world [9]. The two
common  types  of  glaucoma  include  primary  open  angle
glaucoma  (POAG)  and  primary  closed  angle  glaucoma
(PCAG). To date there are conflicting results regarding the
association  of  MTHFR  polymorphisms  with  glaucoma.
Several studies have reported an association of the C677T
polymorphism  with  glaucoma  [10-13],  whereas  in  other
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2268studies,  particularly  in  European  populations,  this
polymorphism appears to play no role in the development of
glaucoma  [14-17].  The  relationship  between  the  A1298C
polymorphism  and  glaucoma  has  been  studied  in  Korean
[13], Swedish [14], and Japanese [15] populations, where no
association has been found between the polymorphism and
glaucoma.
Hyperhomocysteinemia has been observed in patients
with  glaucoma  [17-19].  Bleich  and  coworkers  [19]  found
raised plasma homocysteine levels in Caucasian glaucoma
patients with the C677T polymorphism. Reports from various
countries have revealed high levels of homocysteine in the
aqueous  humor  and  the  serum  of  patients  suffering  from
glaucoma  and  other  ocular  diseases  [17,20-22].
Hyperhomocysteinemia  can  induce  vascular  injuries  [23],
alterations in the extracellular matrix [24], and neuronal cell
death [25,26].
We  recently  reported  a  significant  association  of
MTHFR C677T polymorphism with PCAG in the Pakistani
population, but did not find a significant association of this
mutation with POAG [27]. In the present study, we have
further investigated the C677T and A1298C genotypes in
POAG and PCAG in cohorts of Pakistanis, including two
different ethnic groups (Pathans and Punjabis). We have also
analyzed any possible association of genotypes and combined
genotypes with serum homocysteine levels.
METHODS
Patient  selection  criteria:  Approval  for  the  study  was
obtained  from  the  Institutional  Review  Board/Ethics
Committee.  All  the  patients  were  recruited  from  the  eye
clinics of two different eye hospitals: the Christian Hospital
in Taxila and Al-Shifa Trust Eye Hospital in Rawalpindi.
Patients  from  the  former  hospital  belonged  to  the  Pathan
ethnic group (from the North-West Frontier Province, located
in the north of Pakistan), whereas from the latter the patients
were Punjabi in ethnicity (from the Punjab province, located
in central Pakistan). The selection criteria, the clinical tests
conducted  on  the  patients  and  controls,  as  well  as  the
collection and processing of whole blood were the same as
described  previously  [28].  Peripheral  blood  samples  were
obtained from patient and control groups and collected into
EDTA tubes. Immediately after collection, whole blood was
stored in aliquots at -20 °C until use. Informed consent was
obtained  from  glaucoma  patients  and  normal  volunteers.
Blood was obtained from a total of 295 glaucoma subjects
comprising 173 patients with POAG and 122 patients with
PCAG, and 143 control blood samples were also collected and
processed. The POAG patients had a mean age of 50.4±1.1
years (60% males and 40% females), PCAG patients had a
mean age of 52.4±1.5 years (males: 59%, females 41%) and
control subjects had a mean age of 49.1±1.3 years (males:
72%, females 28%). There was no statistically significant
difference  between  the  mean  age  of  POAG  and  control
subjects (p=0.44) or the distribution of gender in the two
groups  (p=0.07).  Similarly,  there  was  no  statistically
significant difference in the mean age of PCAG and control
subjects (p=0.09) or in the gender distribution of the two
groups (p=0.053).
Polymerase  chain  reaction–restriction  fragment  length
polymorphism  (PCR-RFLP):  The  C677T  MTHFR
polymorphism was genotyped as previously described [27].
Briefly, we used the forward primer 5'-CCT TGA ACA GGT
GGA GGC CAG-3' and the reverse primer 5'-GCG GTG
AGA GTG GGG TGG AG-3'. The mixture was denatured at
95 °C for 10 min, and the PCR reaction was performed for 35
cycles under the following conditions: denaturation at 95 °C
for 1 min, annealing at 65 °C for 30 s, and extension at 72 °C
for 1 min and a final extension cycle of 72 °C was for 7 min.
PCR products were digested with HinfI (Fermentas, Glen
Burnie, MD) and analyzed on agarose gel (3%). A single
fragment of 294 base pairs (bp) was identified as homozygous
(CC); three fragments of 294, 168, and 126 bp were identified
as heterozygous (CT); and two fragments of 168 and 126 bp
were identified as homozygous (TT) genotype. The A1298C
MTHFR polymorphism was genotyped with the help of the
polymerase chain reaction (PCR) followed by digestion of the
amplified  product  with  the  MboII  restriction  enzyme
(Fermentas). Briefly, for PCR, the forward primer 5′-CTT
TGG GGA GCT GAA GGA CTA CTA-3′ and the reverse
primer 5′-CAC TTT GTG ACC ATT CCG GTT TG-3′ were
used  to  amplify  a  163-base  pair  (bp)  fragment  of  the
MTHFR gene. The PCR reactions were performed in a 25 μl
reaction mixture containing 1× Taq Buffer (10 mM Tris-HCl,
pH 9.0, 50 mM KCl, 0.1% Triton X-100, 0.01% [w/v] gelatin,
1.5 mM MgCl2; Fermentas), 30 pmol of each primer, 0.2 mM
of  the  deoxynucleoside  triphosphates,  1  U  of  Taq  DNA
polymerase  (Fermentas),  and  100  ng  of  genomic  DNA
template. The thermal profile used for the PCR amplification
was the same as reported earlier for the C677T amplification
except that the annealing temperature was 62 °C for 30 s. To
confirm the presence of the amplicon of correct size, the PCR
products were electrophoresed on 2% agarose gels (Invitrogen
Corporation, Carlsbad, CA). The amplified products were
then digested with the MboII restriction enzyme as per the
manufacturer’s instructions. After digestion, all the fragments
were resolved on 4% agarose gels. The homozygous normal
allele (AA) produced 5 fragments of 56, 31, 30, 28, and 18 bp
size, the heterozygous (AC) produced 3 fragments of 84, 56,
and 30 bp, whereas the homozygous mutant (CC) produced 4
fragments of 84, 31, 30, and 18 bp.
Total  plasma  homocysteine  determination:  Fasting  blood
samples  of  both  the  patients  and  control  subjects  were
collected  in  plain  vacutainers  (Becton  Dickinson,  Lahore,
Pakistan);  the  plasma  was  separated  with  the  help  of
centrifugation and stored at -35 °C until further analysis. Total
plasma  homocysteine  was  measured  using  a  microplate
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Germany).
Statistical analysis: A logistic regression and multivariate
analysis  was  performed  using  Statistical  Package  for  the
Social  Sciences  (SPSS)  16.0  for  Windows  (SPSS  version
16.0, Chicago, IL). The POAG, PCAG, and control data were
compared  using  the  χ2  test  and  Fisher’s  exact  test.  The
criterion for statistical significance was p<0.05.
RESULTS
MTHFR  C677T  and  A1298C  genotype  analysis:  The
distribution  of  C677T  and  A1298C  genotypes  among  the
controls and the patients did not deviate from those predicted
by the Hardy–Weinberg equilibrium. The distribution of the
MTHFR C677T genotype is shown in Table 1. The collective
data of both ethnic groups revealed that the CC genotype was
present at almost the same frequency in the three groups, i.e.
71% in controls and POAG samples and 69% in the PCAG
group. Similarly, the CT genotype was also present within a
statistically  non-significant  range,  i.e.  controls=29%,
POAG=28%,  and  PCAG=21%.  However,  a  statistically
significant difference (p<0.05, χ2=11.8) was observed in the
distribution of the TT genotype between the controls (1%) and
the PCAG group (10%), with statistical analysis of the overall
comparison of the genotypes also being significantly different
(p<0.05,  χ2=12.6).  There  was  no  difference  between  the
controls and POAG group. When the data for both the ethnic
groups was analyzed separately, the genotypic distribution in
the  Pathan  patient  groups  (POAG  &  PCAG)  was  not
significantly different from the Pathan control samples (Table
1).  However,  the  Punjabi  PCAG  samples  were  not  only
significantly different from the Punjabi control samples in the
overall genotype distribution pattern (p<0.05, χ2=17.2), but
also demonstrated a statistically significant higher frequency
of the mutant TT allele (p<0.05, χ2=10.2) and a significantly
lower distribution of the CT allele (p<0.05, χ2=9.5) than the
controls.
When  the  genotypic  data  of  the  MTHFR  A1298C
polymorphism was studied in the collective dataset (Table 2),
a  significant  difference  was  found  between  the  overall
distribution  of  the  genotype  frequencies  of  PCAG  and
controls  (p<0.05,  χ2=9.7),  with  a  significantly  lower
frequency of the mutant CC genotype in the PCAG group as
compared to the controls (p<0.05, χ2=3.73) as well as a higher
frequency of the AA normal genotype in the PCAG group
when compared to the controls (p≤0.05, χ2=3.7). However,
when the dataset was split up along the lines of ethnicity, the
Pathans did not demonstrate any significant distribution in the
PCAG and POAG groups when compared to the relevant
controls.  Contrarily,  the  Punjabis  showed  a  significant
difference, not only in the overall distribution of the genotypes
(p<0.05, χ2=33.9), but also in the distribution of the different
genotypes: the wild type AA allele being present at a higher
frequency in the PCAG group (43%) as compared to the
controls  (4%),  and  the  heterozygous  AC  and  mutant  CC
alleles  being  present  at  lower  frequencies  (54%  and  3%,
respectively) as compared to the controls (73% and 23%,
respectively).
MTHFR  C677T:A1298C  combined  genotype  analysis:
Combined  genotypes  of  the  C677T  and  A1298C
polymorphisms of the MTHFR gene were also obtained for
the collective data of both populations, as well as for the
Pathans and Punjabis separately (Table 3 and Table 4). In the
case  of  POAG,  no  statistically  significant  difference  was
observed  when  the  collective  data  (p=0.83,  χ2=2.8)  were
analyzed  or  when  the  ethnic  groups  were  considered
separately (Pathan: p=0.31, χ2=7.1, Punjabi: p=0.71, χ2=3.7;
Table 3). However, when the combined genotype data of the
PCAG samples were analyzed, a significant difference was
observed  for  the  collective  samples  (p<0.05,  χ2=20.1),
particularly for the samples containing the TT alleles (p<0.05,
χ2=6.9; Table 4), and this was true for the TTAA as well as
the  TTAC  genotypes  (p<0.05,  χ2=5.9,  p<0.05,  χ2=5.7,
respectively).
When the combined genotypes of the ethnic groups were
considered  separately,  in  the  Pathans  no  statistically
significant difference was observed in the overall distribution
of the alleles when compared with the controls, as well as in
the case of any of the combined genotypes (Table 4). As
opposed to this, when the overall data of the PCAG Punjabi
samples were compared with the controls (Table 4), there was
a  significant  difference  in  the  distribution  patterns  of  the
combined genotypes (p<0.05, χ2=49.6), with almost all the
genotypes showing a difference in the affected individuals
compared with the controls. Both TTAA and TTAC, which
were present at a frequency of 7% in the PCAG group, were
absent in the controls (p<0.05, χ2=4.6). The CCAA combined
genotype was also found to be present at a higher frequency
in the Punjabi PCAG group (28%) as compared to the controls
(4%), which was statistically significant (p<0.05, χ2=14.8).
The same was the case for CTAA (PCAG=8%, controls=0%,
p<0.05, χ2=6.2). But the CCCC and CTCC genotypes were
present at a lower frequency in the affected individuals (3%
and 0%, respectively) as compared to the controls (17% and
7%,  respectively),  which  was  also  statistically  significant
(p<0.05, χ2=6.2 and p<0.05, χ2=4.3, respectively).
MTHFR  gene  polymorphism  and  homocysteine
concentrations: The associations of different genotypes with
levels of tHcy were determined in a subgroup of the controls,
POAG,  and  PCAG  patients  that  were  age-  and  gender
matched. As shown in Figure 1, the mean value of tHcy in the
POAG  (15.2±1.28  µmol/l)  and  PCAG  (20.8±4.8  µmol/l)
patients  was  found  to  be  significantly  higher  than  in  the
controls  (10.0±0.97  µmol/l).  When  tHcy  levels  were
compared across different genotypes in the controls, in the
case of the C677T polymorphism it was found that, compared
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2272with  the  normal  CC  genotype,  the  TT  genotype  had
significantly (p<0.001) elevated tHcy levels in the controls
(22 µmol/l±0.0 µmol/l) as well as in the POAG (32 µmol/l
±0.0 µmol/l) and PCAG (67 µmol/l±12.39 µmol/l) groups
(Figure 2). In addition, when the A1298C MTHFR genotypes
were compared, both the PCAG (23±5.94 µmol/l, p<0.027)
and POAG (16±1.51 µmol/l, p<0.001) groups were found to
have significantly elevated levels of tHcy in the AC genotype
as compared to the controls (12±1.25 µmol/l; Figure 2). When
the  levels  of  tHcy  were  compared  against  the  combined
genotypes, the TTAC had significantly elevated levels (67
µmol/l±12.4  µmol/l;  p<0.001),  whereas  the  rest  of  the
combined genotypes had comparable levels of tHcy between
the controls and the POAG and PCAG patients. Based upon
the  Wilks’  lambda,  the  multivariate  analysis  of  variance
analysis indicates that the tHcy levels differed significantly
across the three groups (i.e. controls, POAG, and PCAG) with
respect  to  the  C677T  (F=9.985,  p=<0.001),  but  not  the
A1298C (F=2.543, p=0.098) genotype.
Figure 1. Mean plasma homocysteine levels in controls, POAG, and
PCAG subjects. Error bars indicate standard error of the mean.
TABLE 3. COMBINED GENOTYPE ANALYSIS OF METHYLTETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM WITH PRIMARY OPEN ANGLE GLAUCOMA AND CONTROLS.
Combined Subjects
C677T A1298C Controls (143) POAG (173) OR (95%CI) p (χ2) p (χ2)
CC AA 14 (10%) 25 (14%) 0.64 (0.32-1.28) 0.32 (2.2) 0.83 (2.8)
CC AC 66 (46%) 79 (46%) 1.02 (0.65-1.59)
CC CC 21 (15%) 19 (11%) 1.39 (0.72-2.69)
CT AA 6 (4%) 10 (6%) 0.71 (0.26-1.94) 0.76 (0.54)
CT AC 30 (21%) 34 (20%) 1.08 (0.63-1.87)
CT CC 5 (3%) 5 (3%) 1.22 (0.37-4.01)
TT AA 0 (0%) 0 (0%) -------- 0.51 (1.3)
TT AC 1 (1%) 1 (1%) 1.21 (0.12-11.70)
TT CC 0 (0%) 0 (0%) -------
Subjects of Pathan Ethnicity
C677T A1298C Controls (70) POAG (96) OR (95%CI) p (χ2) p (χ2)
CC AA 11 (16%) 21 (22%) 0.67 (0.30-1.47) 0.09 (4.6) 0.31 (7.1)
CC AC 33 (47%) 45 (47%) 1.01 (0.55-1.87)
CC CC 9 (13%) 4 (4%) 3.39 (1.05-10.85)
CT AA 6 (9%) 8 (8%) 1.03 (0.36-2.99) 0.68 (0.76)
CT AC 10 (14%) 17 (18%) 0.77 (0.34-1.79)
CT CC 0 1 (1%) 0.00 (0.00-5.29)
TT AA 0 0 -------- N/A
TT AC 1(1%) 0 --------
TT CC 0 0 --------
Subjects of Punjabi Ethnicity
C677T A1298C Controls (73) POAG (77) OR (95%CI) p (χ2) p (χ2)
CC AA 3 (4%) 4 (5%) 0.78 (0.19-3.25) 0.88 (0.24) 0.71 (3.7)
CC AC 33 (45%) 34 (44%) 1.04 (0.55-1.98)
CC CC 12 (17%) 15 (20%) 0.81 (0.36-1.85)
CT AA 0 2 (3%) 0.00 (0.00-2.02) 0.32 (2.2)
CT AC 20 (27%) 17 (22%) 1.33 (0.64-2.79)
CT CC 5 (7%) 4 (5%) 1.34 (0.37-4.82)
TT AA 0 0   N/A
TT AC 0 1 (1%)  
TT CC 0 0  
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2273DISCUSSION
SNPs of the MTHFR gene have been shown to be associated
with mild hyperhomocysteinemia. Bleich et al. [19] were the
first to demonstrate an association between increased plasma
homocysteine levels and POAG, which suggested evidence of
its involvement in the pathogenesis of glaucomatous optic
neuropathy.  Subsequently,  Altintas  et  al.  [29]  also
demonstrated  that  elevation  in  the  levels  of  tHcy  is  also
associated with pseudoexfoliative glaucoma. We report here
a markedly increased level of serum tHcy in Pakistani PCAG
patients as compared to POAG patients and controls. To the
best of our knowledge, this is the first study to show an
association of hyperhomocysteinemia with PCAG. We have
previously  observed  PCAG  to  be  associated  with  the
MTHFR C677T polymorphism in a Pakistani cohort [27];
however,  at  that  time  we  did  not  study  the  A1298C
polymorphism  or  the  combined  genotype  frequency
distributions of the two polymorphisms. Our previous study
included patients and controls from a mixed population of
Punjabis (from the Punjab province in central Pakistan) and
Pathans (from the N.W.F.P. province in the north of Pakistan).
In  this  study,  we  also  investigated  any  correlation  of  the
disease with the ethnic origin of the patients being studied.
Consistent with our previous report [27], we found no
association of the MTHFR C677T genotype with POAG but
Figure 2. Mean plasma homocysteine levels in C677T and A1298C
genotypes  in  controls,  POAG,  and  PCAG  samples.  Error  bars
indicate standard error of the mean.
TABLE 4. COMBINE GENOYPE ANALYSIS OF METHYLTETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM WITH PRIMARY CLOSED ANGLE GLAUCOMA AND CONTROLS.
Combined Subjects
C677T A1298C Controls (143) PCAG (122) OR (95%CI) p (χ2) p (χ2)
CC AA 14 (10%) 22 (18%) 0.49 (0.24-1.00) 0.05 (5.8) 0.005 (20.1)
CC AC 66 (46%) 52 (43%) 1.15 (0.71-1.87)
CC CC 21 (15%) 10 (8%) 1.93 (0.88-4.20)
CT AA 6 (4%) 7 (6%) 1.72 (0.25-2.10) 0.43 (1.7)
CT AC 30 (21%) 17 (14%) 1.64 (0.86-3.12)
CT CC 5 (3%) 2 (2%) 2.17 (0.48-9.87)
TT AA 0 (0%) 5 (4%) 0.00 (0.00-0.63) 0.03 (6.9)
TT AC 1 (1%) 7 (6%) 0.12 (0.02-0.74)
TT CC 0* (0%) 0 (0%) --------
Subjects of Pathan Ethnicity
C677T A1298C Controls (70) PCAG (61) OR (95%CI) p (χ2) p (χ2)
CC AA 11 (16%) 5 (8%) 2.09 (0.71-6.12) 0.62 (0.97) 0.19 (9.8)
CC AC 33 (47%) 25 (41%) 1.28 (0.64-2.56)
CC CC 9 (13%) 8 (13%) 0.98 (0.36-2.64)
CT AA 6 (9%) 2 (3%) 2.77 (0.61-12.41) 0.09 (4.8)
CT AC 10 (14%) 15 (25%) 0.51 (0.21-1.23)
CT CC 0 2 (3%) 0.00 (0.00-1.67)
TT AA 0 1 (2%) 0.00 (0.00-3.58) N/A
TT AC 1 (1%) 3 (5%) 0.28 (0.04-2.03)
TT CC 0 0 ---------
Subjects of Punjabi Ethnicity
C677T A1298C Controls (73) PCAG (61) OR (95%CI) p (χ2) p (χ2)
CC AA 3 (4%) 17 (28%) 0.11 (0.03-0.38) 0.001 (17.5) <0.001 (49.6)
CC AC 33 (45%) 27 (44%) 1.04 (0.53-2.05)
CC CC 12 (17%) 2 (3%) 5.80 (1.38-24.03)
CT AA 0 5 (8%) 0.00 (0.00-0.61) <0.001(21.4)
CT AC 20 (27%) 2 (3%) 11.13 (2.74-44.64)
CT CC 5 (7%) 0 ----------
TT AA 0 4 (7%) 0.00(0.00-0.77) N/A
TT AC 0 4 (7%) 0.00(0.00-0.77)
TT CC 0 0 ----------
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2274a very strong association with PCAG, which is probably due
to the presence of the TT genotype in the disease cohort and
its complete absence from the control population (Table 1).
When  the  samples  were  analyzed  along  ethnic  lines,  the
Pathans did not show any of the genotypes to be associated
with POAG or PCAG, but the Punjabis showed a highly
significant association of PCAG with the genotypes. In the
Punjabis, both the genotypes containing the mutant alleles, i.e.
CT and TT, were found to be significantly associated with the
disease, the former because it was present at a much lower
frequency in the affected individuals and the latter because it
was present at a higher frequency. The C677T C>T mutation
causes  an  alanine>valine  amino  acid  substitution,  which
results in a 55–65% loss in enzyme activity especially in
individuals who are homozygous for the mutation (TT), while
in the case of heterozygotes (CT) there is a 25% loss in activity
compared to CC homozygous normal individuals [30,31],
leading  to  hyperhomocysteinemia.  Interestingly,  when  the
tHcy levels were determined, a significantly higher level was
observed in the PCAG subjects as compared to the POAG
subjects and controls (Figure 1). This elevated tHcy level in
PCAG  may  be  mediated  by  the  increased  level  of  tHcy
observed in the TT genotype samples of these patients (Figure
2). Although tHcy levels in the TT genotype were also higher
in the controls and the POAG samples compared to the other
genotypes, in the case of PCAG these levels were the highest
observed,  which  correlates  very  well  with  the  genotypic
association of TT with PCAG.
PCAG  patients  have  characteristic  biometric  ocular
features,  including  a  shallow  anterior  chamber,  increased
thickness of the lens, and a short axial length. It has been
suggested that extracellular matrix (ECM) remodeling maybe
an  important  determinant  of  the  short  axial  length  [32].
Evidence has suggested restructuring of the sclera in acute
PCAG [33]. As discussed previously [27], we propose that the
high level of homocysteine found in our PCAG subjects is
contributing to the remodeling of the ECM of the anterior
segment in these patients. Hyperhomocysteinemia has been
shown  to  be  involved  in  the  structural  remodeling  of
connective tissues [34]. Matrix metalloproteases (MMPs) are
a class of proteases that are involved in tissue remodeling
under certain pathological and physiological conditions [35].
Lui et al. [36] have reported the expression of MMP-9, which
cleaves type IV collagen and is important for the remodeling
of the ECM, to be decreased in the Tenon’s capsule of PCAG
patients. Moreover, Seo et al. [37] have shown differential
expression  of  MMP-2  in  PCAG  as  compared  to  POAG.
Recent  literature  supports  the  hypothesis  that  these
differential  expressions  may  be  altered  by  variations  in
homocysteine levels. Kundu et al. [38] have reported MMP-2,
MMP-9, and MMP-14 to be affected by homocysteine levels
in the cochlea, and suggest that homocysteine induces matrix
imbalance, structural changes, and oxidative stress via the
extracellular  signal-regulated  kinase  (ERK)  signaling
pathway [39]. Therefore, it appears logical that the enhanced
activity of MTHFR results in hyperhomocysteinemia and in
turn may induce differential expression of MMPs leading to
tissue  remodeling,  thereby  contributing  to  the  disease
pathogenesis of these PCAG patients.
When the A1298C mutation was studied in the different
samples, no association was observed with POAG, as the
frequency distribution in the combined subjects or the Pathan
and Punjabi patients was not significantly different from the
controls. This is in agreement with previous studies, which
also did not observe any association of this polymorphism
with POAG [13,15]. However, when the PCAG samples were
compared  with  the  controls,  significant  differences  were
found in the Punjabis but not in the Pathans. The Punjabi
subjects had a significantly higher normal AA genotype and
lower homozygous CC frequency in PCAG as compared to
the  controls.  These  results  are  surprising  and  indicate  a
protective role for MTHFR A1298C mutant alleles in PCAG
patients. Although PCAG is primarily an anatomical defect,
recent evidence suggests that oxidative stress may play a role
in the pathogenesis of PCAG [40]. Decreased activity of the
MTHFR  leads  not  only  to  increased  levels  of  plasma
homocysteine,  as  reported  here,  but  simultaneously  to
increased DNA synthesis. In this case, there is a possibility
that there is an increased DNA synthesis in PCAG patients
with the MTHFR A1298C polymorphism, that may produce
a counter effect on oxidative-stress-induced DNA damage.
Our combined genotype data also does not reveal any
association of the different combinations with POAG, either
in the combined subjects or in the Punjabi and Pathan ethnic
groups. We also did not find a single double homozygous
mutant (TT/CC) in any of the controls or disease samples. This
is in accordance with previous reports in which it has been
suggested  that  both  mutations  cannot  be  simultaneously
associated  with  glaucoma  because  both  polymorphisms
always occur in the trans form and not in the cis configuration
[31]. A very strong association of the combined genotypes,
particularly those containing the TT alleles of the C677T
locus,  was  found  with  PCAG.  When  we  separated  the
combined genotypes along the line of ethnicity, here again,
only the Punjabis showed a very strong association of TT/AA
and TT/AC with PCAG. A limitation of the study was that we
were not able to compare the TT/AA combined genotype as
there were no controls and POAG samples in this group, and
so it is not possible to state whether the high levels of tHcy in
the PCAG was a result of the TT genotype alone or due to the
combined effect of TT/AC genotypes. It has been suggested
that the A1298C polymorphism alone does not significantly
affect tHcy, but does so with the combination of the 677T
variant [41]. It is worth pointing out that in the Punjabis there
was  an  unexpectedly  higher  frequency  of  the  CCAA
combination in the PCAG group as compared to the controls
(Table 4), and even when compared with the Punjabi POAG
samples (Table 3). This is because of the higher than usual
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2275frequency of the AA allele in the Punjabi PCAG samples as
compared to either the controls or the Pathan samples (Table
2), which could be a result of the sample size or some other
factor yet to be identified, but is definitely not a result of higher
tHcy levels in this genotype.
This study is the first to report an association of the TT
genotype, TT/AC combined genotypes, and high tHcy levels
with  PCAG.  Although  correlations  of  high  homocysteine
levels with the TT genotype and the TT/AC combination of
MTHFR have also been reported in other diseases [31,41,
42], we found the levels of tHcy to be much higher in PCAG.
We suggest that this individual or combined genotype may
not be sufficient to account for such high levels of tHcy in the
PCAG  subjects,  as  tHcy  levels  have  been  known  to  be
dependent not only on MTHFR mutations but also on other
factors,  such  as  folate  and  vitamin  B12  status  [22,43].
Moreover,  the  nicotinamide  N-methyltransferase  gene  has
been reported to be the major genetic determinant of plasma
homocysteine levels [43]. The high tHcy levels observed in
this  study  may,  however,  be  used  as  an  early  diagnostic
biomarker for PCAG following required prospective studies.
The  present  investigation  also  provides  evidence  of  the
importance  of  conducting  such  studies  in  different  ethnic
groups,  as  even  in  closely  living  populations  such  as  the
Pathans  and  Punjabis,  there  is  clearly  a  difference  in
frequencies of genotypes and combined genotypes leading to
different associations with disease.
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